|
Volumn 8, Issue 5, 1995, Pages 215-224
|
31P magnetic resonance spectroscopy as predictor of clinical response in human extremity sarcomas treated by single dose TNF‐α+ melphalan isolated limb perfusion
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MELPHALAN;
PHOSPHATE;
PHOSPHORUS;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
FEMALE;
HUMAN;
MALE;
METABOLISM;
METHODOLOGY;
MIDDLE AGED;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PREDICTION AND FORECASTING;
REGIONAL PERFUSION;
SARCOMA;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, CANCER, REGIONAL PERFUSION;
FEMALE;
HUMANS;
MAGNETIC RESONANCE SPECTROSCOPY;
MALE;
MELPHALAN;
MIDDLE AGED;
PHOSPHATES;
PHOSPHORUS;
PREDICTIVE VALUE OF TESTS;
SARCOMA;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0029348482
PISSN: 09523480
EISSN: 10991492
Source Type: Journal
DOI: 10.1002/nbm.1940080506 Document Type: Article |
Times cited : (38)
|
References (36)
|